Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines, No. 009, October 2004
(2004; 6 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentWhy pharmacovigilance is needed
View the documentThe aims of pharmacovigilance
Open this folder and view contentsPartners in pharmacovigilance
View the documentCommunicating the outcome of pharmacovigilance
View the documentWHO Programme for International Drug Monitoring
View the documentConclusion
View the documentKey documents
 

Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines, No. 009, October 2004

October 2004
World Health Organization Geneva

Modern medicines have changed the way in which diseases are managed and controlled. However, despite all their benefits, evidence continues to mount that adverse reactions to medicines are a common, yet often preventable, cause of illness, disability and even death. In some countries, adverse drug reactions (ADRs) rank among the top 10 leading causes of mortality. Aside from the intrinsic dangers associated with the products them-selves, individual patients may exhibit particular and unpredictable sensitivities to certain medicines. In addition, if more than one medicine is prescribed, there is always a risk of negative interactions. The selection and use of the best and safest medicine(s) for a given individual out of the many choices avail-able thus requires considerable skill on behalf of the prescribing practitioner.

In order to prevent or reduce harm to patients and thus improve public health, mechanisms for evaluating and monitoring the safety of medicines in clinical use are vital. In practice this means having in place a well-organized pharmacovigilance system. Pharmacovigilance - an umbrella term used to describe the processes for monitoring and evaluating ADRs - is a key component of effective drug regulation systems, clinical practice and public health programmes.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014